Use of clobazam for the treatment of refractory complex partial seizures

Seizure

Volumn 12, Issue 5, 2003, Pages 282-286

  Shimizu, Hisako ^a   Kawasaki, Jun ^a   Yuasa, Shoji ^b   Tarao, Yoko ^c   Kumagai, Sachiyo ^c   Kanemoto, Kousuke ^c  

^a UTANO NATIONAL HOSPITAL   (Japan)

^b Fukuchi Clinic   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Add on therapy; Clobazam; Complex partial seizures

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLOBAZAM; PHENOBARBITAL; PHENYTOIN; ZONISAMIDE;

ADD ON THERAPY; ADULT; ANOREXIA; ARTICLE; CLINICAL STUDY; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; DRUG USE; DRUG WITHDRAWAL; FEMALE; GAIT DISORDER; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL CONCENTRATION; MENTAL INSTABILITY; NAUSEA; PRIORITY JOURNAL; PSYCHOSIS; REMISSION; SOMNOLENCE; TONIC CLONIC SEIZURE; TREATMENT OUTCOME; TREMOR; VERTIGO;

EID: 0038759981     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1059-1311(02)00287-X     Document Type: Article

References (27)

1. Gastaut, H. and Low, M. D. Antiepileptic properties of clobazam, a 1,5-benzodiazepine, in man. Epilepsia 1979; 20: 437-446.
2. Watanabe, M., Yagi, K. and Seino, M. An open clinical trial of a newly developed antiepileptic drug, clobazam, on treatment-resistant epileptic seizures. Seishinigaku 1992; 34: 757-766.
3. Wolf, P. Clobazam in drug-resistant patients with complex focal seizures - report of an open study. In: Clobazam: Human Psychopharmacology and Clinical Applications, International Congress and Symposium Series, No. 74 (Eds I. Hindmarch, P. D. Stonier and M. R. Trimble). London, Royal Society of Medicine, 1985: p. 167.
4. Schmidt, D. Clobazam for treatment of intractable epilepsy: a critical assessment. Epilepsia 1994; 35 (Suppl. 5): S92-S95.
5. Remy, C. Clobazam in the treatment of epilepsy: a review of the literature. Epilepsia 1994; 35 (Suppl. 5): S88-S91.
6. Barcs, G. and Halasz, P. Effectiveness and tolerance of clobazam in temporal lobe epilepsy. Acta Neurologica Scandinavica 1996; 93: 88-93.
7. Franceschi, M., Ferini-Strambi, L. and Mastrangelo, M. Clobazam in drug-resistant and alcoholic withdrawal seizures. Clinical Trials Journal 1983; 20: 119.
8. Yagi, K., Seino, M., Takeda, A., Kawai, I. and Sengoku, A. Open clinical trials of NH-15 (clobazam) on refractory epilepsies - early phase II study and long-term study. Japanese Journal of Neuropsychopharmacology 1995; 17: 161-173.
9. Sennoune, S., Mesdjian, E., Bonneton, J., Genton, R, Dravet, C. and Roger, J. Interactions between clobazam and standard antiepileptic drugs in patients with epilepsy. Therapy&Drug Monitoring 1992; 14: 269-274.
10. Cocks, A., Critchley, E. M. R. and Hayward, H. W. The effect of clobazam on the blood levels of sodium valproate. In: Clobazam: Human Psychopharmacology and Clinical Applications, International Congress and Symposium Series, No. 74 (Eds I. Hindmarch, P. D. Stonier and M. R. Trimble). London, Royal Society of Medicine, 1985: pp. 155-157.
11. Genton, P., Nguyen, V. H. and Mesdjian, E. Carbamazepine intoxication with negative myoclonus after the addition of clobazam. Epilepsia 1998; 39: 1115-1118.
12. Zifkin, B., Sherwin, A. and Andermann, F. Phenytoin toxicity due to interaction with clobazam. Neurology 1991; 41: 313-314.
13. Allen, J. W., Oxley, J., Robertson, M. M. et al. Clobazam as adjunctive treatment in refractory epilepsy. British Medical Journal 1983; 286: 1246-1247.
14. Farrell, K. Benzodiazepines in the treatment of children with epilepsy. Epilepsia 1986; 27 (Suppl. 1): S45-S52.
15. Trimble, M. R. Forced normalization and the role of anticonvulsants. In: Forced Normalization and Alternative Psychoses of Epilepsy (Eds M. R. Trimble and B. Schmitz). London, Wrightson Biochemical Publishing, 1998: pp. 169-178.
16. Kanemoto, K., Kim, Y., Miyamoto, T. et al. Presurgical postictal and acute interictal psychoses are differentially associated with postoperative mood and psychotic disorders. Journal of Neuropsychiatry and Clinical Neurosciences 2001; 13: 243-247.
17. Canadian Study Group for Childhood Epilepsy. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Epilepsia 1998; 39: 952-959.
18. Guberman, A., Couture, M., Blaschuk, K. and Sherwin, A. Add-on trial of clobazam in intractable adult epilepsy with plasma level correlations. Canadian Journal of Neurological Science 1990; 17: 311-316.
19. Montenegro, M. A., Cendes, F., Noronha, A. L. et al. Efficacy of clobazam as add-on therapy in patients with refractory partial epilepsy. Epilepsia 2001; 42: 539-542.
20. Keene, D. L., Whiting, S. and Humphreys, P. Clobazam as an add-on drug in the treatment of refractory epilepsy of childhood. Canadian Journal of Neurological Science 1990; 17: 317-319.
21. Koeppen, D., Baruzzi, A. and Capozza, M. Clobazam in therapy-resistant patients with partial epilepsy: a double-blind placebo-controlled crossover study. Epilepsia 1987; 28: 495-506.
22. Robertson, M. M. Current status of the 1,4- and 1,5-benzodiazepine in the treatment of epilepsy: the place of clobazam. Epilepsia 1986; 27 (Suppl. 1): S27-S41.
23. Dalby, M. A. Clobazam in resistant epilepsy: a retrospective survey. In: Clobazam: Human Psychopharmacology and Clinical Applications, International Congress and Symposium Series, No. 74 (Eds I. Hindmarch, P. D. Stonier and M. R. Trimble). London, Royal Society of Medicine, 1985: P. 189.
24. Singh, A., Guberman, A. H. and Boisvert, D. Clobazam in long-term epilepsy treatment: sustained responders versus those developing tolerance. Epilepsia 1995; 36: 798-803.
25. Canadian Clobazam Cooperative Group. Clobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective study. Epilepsia 1991; 32: 407-416.
26. Haigh, J. R., Gent, J. P., Garratt, J. C. et al. Disappointing results of increasing benzodiazepine dose after the development of anticonvulsant tolerance. Journal of Neurology, Neurosurgery and Psychiatry 1988; 51: 1008-1009.
27. Bawden, H. N., Camfield, C. S., Camfield, P. R. et al. The cognitive and behavioural effects of clobazam and standard monotherapy are comparable. Canadian Study Group for Childhood Epilepsy. Epilepsy Research 1999; 33: 133-143.